Perspective · 2 Feb 2026
Conference abstractPublished 1 Oct 2012
A friedreich’s ataxia neuronal cell model with evidence of oxidative stress-mediated neurodegeneration
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
F riedreich?s ataxia (FRDA) is caused by severely reduced levels of frataxin as a result of a large GAA triplet-repeat expansion within the first intron of the frataxin gene. The prominent feature of this pathology is the neurodegeneration interesting both central and peripheral nervous systems. A distal length-related axonal degeneration affects upper motor neurons of the corticospinal tract, the posterior columns of the spinal cord, the spinocerebellar tract and the large sensory fibers of the peripheral nerves. To date, there is still no known pharmacological treatment that cures, or even slows down, FRDA neuropathology. Indeed, the study of the selective vulnerability of specific neurons to frataxin deficiency is make it difficult by the scarce accessibility of the nervous tissue and by the lack of an appropriate neuronal cell model which reproduces the pathophysiology associated to FRDA. We developed for the first time an in vitro system of FRDA neuronal degeneration by using the NSC34 motoneuronal cell line in which frataxin deficiency was obtained via shRNA gene silencing with a reduction of the protein ranging from 30% to 60% of the normal level. Frataxin-silenced NSC34 cells show a specific inhibition of mitochondrial Complex I activity and undergo to oxidative stress evidenced by a dramatic glutathione unbalance. In addition, FRDA cells show a decrease of cell proliferation rate. Interestingly, the in vivo treatment with the permeable form of glutathione (EE-GSH) cause a significant induction of cell proliferation and the in vitro re-activation of Complex I. Our neuronal cell model have the potential to provide an experimentally accessible cell population to allow a more detailed examination, not only of nervous tissue specific FRDA pathophysiology, but also of oxidative stress-mediated neurodegeneration. In addition, it suggests glutathione as possible target for new therapeutic treatments.
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Cell Science & Therapy.
Commentary · 2 Feb 2026
Metabolism Regulation and Its Influence on Therapeutic Development in Human Disease
Commentary · 2 Dec 2025
Cellular Membranes and Transport Proteins as Regulators of Homeostasis and Metabolic Coordination
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Barbara Carletti”
